​FSSAI Launches Nationwide Festive Enforcement Drive to Curb Adulteration; Directs Real-Time Surveillance via FoSCoS and Mobile Testing Units

Date:

Share post:

 The Food Safety and Standards Authority of India (FSSAI) has instructed all States and Union Territories to strengthen surveillance and enforcement against unsafe and adulterated food during the coming festive season.

In an official communication addressed to the Commissioners of Food Safety of all States and UTs and to FSSAI’s Regional Directors, the Authority noted that consumption of sweets, savouries, beverages, edible oils and dairy products such as ghee, khoa and paneer rises sharply around Navratri and Diwali. Such demand, it cautioned, increases the risk of substandard, counterfeit and adulterated products reaching consumers.

The priority categories are milk and milk products, sweets, snacks and savouries (including namkeen, papad and fryums), edible oils, beverages and ghee. States may adjust this list to local consumption patterns, for example flours such as kuttu and singhada atta in northern and western regions.

Designated Officers and Food Safety Officers have been asked to carry out inspections and collect samples, concentrating on identified hotspots and sensitive locations. Where available, Food Safety on Wheels mobile units are to be deployed in major markets or on the basis of intelligence inputs. They will provide on-the-spot testing, raise public awareness and strengthen consumer confidence in festive foods.

All inspection and sampling data, along with outcomes, must be recorded on the FoSCoS/FoSCoRIS platforms in real time.

The communication, issued under the signature of Dr. Amit Sharma, Executive Director (CS).

Written By: Sayan Das

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Pharma’s AI Shift Will Depend More on Data Readiness Than Algorithms: Experts

As pharmaceutical companies race to adopt artificial intelligence across discovery, development and manufacturing, industry experts say the decisive...

ViiV Healthcare’s Long-Acting Cabenuva Demonstrates Superior Viral Suppression Over Daily Oral Therapy in People with Viremia

GSK plc (LSE/NYSE: GSK) and ViiV Healthcare, the global specialist HIV company majority-owned by GSK with Shionogi as a shareholder,...

Department of Pharmaceuticals and NPPA Enforce 30% Trade Margin Cap on Non-Scheduled Anti-Cancer Drugs to Strengthen Pricing Transparency

In a targeted regulatory initiative to expand the affordability of critical oncology care, the Department of Pharmaceuticals under...

EVERSANA and Pulse Infoframe Announce Strategic Partnership to Deliver Global Real-World Evidence and HEOR Solutions

EVERSANA®, a leading global commercial services provider to the life sciences industry, and Pulse Infoframe Inc., a real-world evidence (RWE)...